drugset / Trial / NCT02871479
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Phase 2
Completed
71 enrolled
Santalis Pharmaceuticals, Inc.
ClinDatrix, Inc. · collabClinical Trials of Texas, Inc. · collabDerm Research, PLLC · collabProgressive Clinical Research · collabTexas Dermatology and Laser Specialists · collabU.S. Dermatology Partners Bryan · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial will be a double-blind, randomized, placebo-controlled, safety, tolerability and efficacy trial of SAN007 (5% East Indian sandalwood oil in a cream formulation) treatment regimen when administered daily for up to 28 days to patients at least 18 years of age, with atopic dermatitis.
Timeline
- Start
- 2017-04-21
- Primary completion
- 2018-08-31
- Completion
- 2018-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAN007 | Unknown | 5 % | Topical |
| Subject | SAN007 | Unknown | 10 % | Topical |